©
Anna Pellat, MD, MSc
I have been working on transparency and levels of evidence of research in pancreatic adenocarcinoma. Following my initial work, I am now focusing on the role of observational studies and evaluating how it challenges the current framework of evidence in medical research.
In parallel, I am also associated with the ESMO real-world and digital health working group where I work on several projects regarding real-world evidence in oncology. I am co-leading one of the projects.
Finally, as a medical doctor, I also work part-time in the digestive oncology department of the Cochin hospital in Paris, where I will then pursue my academic career at the end of my PhD.
Research interests
Digestive oncology
Framework of evidence in medical research
Observational and real-world evidence in clinical oncology research
Key publications
Levels of Evidence Supporting United States Guidelines in Pancreatic Adenocarcinoma Treatment. Pellat A, Boutron I, Coriat R, Ravaud P.Cancers (Basel). 2022 Aug 22;14(16):4062. [Paper]
Availability of Results of Trials Studying Pancreatic Adenocarcinoma over the Past 10 Years. Pellat A, Boutron I, Ravaud P.Oncologist. 2022 Nov 3;27(11):e849-e855. [Paper]